Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2007 5
2008 3
2009 5
2010 9
2011 8
2012 10
2013 9
2014 15
2015 14
2016 17
2017 15
2018 15
2019 18
2020 20
2021 30
2022 24
2023 21
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M. Taki M, et al. Among authors: matsumura n. Clin Cancer Res. 2021 Sep 1;27(17):4669-4679. doi: 10.1158/1078-0432.CCR-20-4459. Epub 2021 Apr 7. Clin Cancer Res. 2021. PMID: 33827891 Review.
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M, Abiko K, Yamaguchi K, Nakai H, Baba T, Matsumura N, Yoshizawa A, Ueno H, Mandai M. Ukita M, et al. Among authors: matsumura n. JCI Insight. 2022 Jun 22;7(12):e157215. doi: 10.1172/jci.insight.157215. JCI Insight. 2022. PMID: 35552285 Free PMC article.
B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M. Miyamoto T, et al. Among authors: matsumura n. Cancer Immunol Res. 2022 Jan;10(1):56-69. doi: 10.1158/2326-6066.CIR-21-0407. Epub 2021 Nov 19. Cancer Immunol Res. 2022. PMID: 34799346 Free PMC article.
Who benefits from the abscopal effect?
Matsumura N. Matsumura N. Int Cancer Conf J. 2023 May 23;12(3):167. doi: 10.1007/s13691-023-00616-8. eCollection 2023 Jul. Int Cancer Conf J. 2023. PMID: 37251012 No abstract available.
Increasing our knowledge of germline variants.
Matsumura N. Matsumura N. Int Cancer Conf J. 2022 Jan 20;11(1):1. doi: 10.1007/s13691-021-00529-4. eCollection 2022 Jan. Int Cancer Conf J. 2022. PMID: 35127312 Free PMC article. No abstract available.
From genetic analysis to precision medicine.
Matsumura N. Matsumura N. Int Cancer Conf J. 2021 Jun 11;10(3):159. doi: 10.1007/s13691-021-00492-0. eCollection 2021 Jul. Int Cancer Conf J. 2021. PMID: 34221824 Free PMC article. No abstract available.
A message from the new editor-in-chief.
Matsumura N. Matsumura N. Int Cancer Conf J. 2020 Mar 27;9(2):51. doi: 10.1007/s13691-020-00410-w. eCollection 2020 Apr. Int Cancer Conf J. 2020. PMID: 32257752 Free PMC article. No abstract available.
216 results